China Semaglutide Powder Suppliers, Manufacturers, Factory Wholesale Price
AbbVie’s anti-inflammatory blockbuster Humira (adalimumab) used to be one of the top-selling drugs worldwide, with the drug generating $21.2bn in sales in its last year of market exclusivity in 2023. Whilst still a heavyweight in the monoclonal antibody arena, revenue is forecast to slump to $2.6bn by 2030, as per a separate analysis by GlobalData. […]
China Semaglutide Powder Suppliers, Manufacturers, Factory Wholesale Price Leer más »
